In today’s episode, we will start with a quick introduction to Immuno-Oncology. We will then look in to the evolution of this concept followed by the current situation and finally, we will touch briefly on the road-ahead for Immuno-Oncology.
We would love to hear from our audiences on which Immuno-oncology therapies you think have shaped today’s treatment paradigm?
Zahid Nabi
Zahid joined RAS in 2015 and since then he has been involved in several projects including competitive intelligence, strategy analysis, market analysis
Zahid brings in 12 years of professional experience spanning across consulting, medicinal and synthetic chemistry.